Stay updated on Nivolumab & Lenvatinib in HCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Lenvatinib in HCC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating that enrollment has ended. New sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, the Intervention / Treatment header was standardized to Intervention/Treatment, and a Revision: v3.6.0 note was added.
    Difference
    0.4%
    Check dated 2026-06-13T04:28:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5. This reflects a minor platform update to the page rendering rather than changes to study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:10.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Footer now displays the revised site version 'Revision: v3.5.4', replacing 'Revision: v3.5.3'. This marks a minor update to the page template.
    Difference
    0.1%
    Check dated 2026-05-15T14:59:03.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a newer software/site revision identifier (“Revision: v3.5.3”) rather than the previous one (“Revision: v3.5.2”). This reflects a version update of the ClinicalTrials.gov page tooling rather than any change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:05.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:52.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Added the hepatocellular carcinoma term and a Genetic and Rare Diseases Information Center resource; updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T22:44:46.000Z thumbnail image

Stay in the know with updates to Nivolumab & Lenvatinib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.